- About About
Medical Patient Resources Cannabis Care Certification Patient's Guide to Medical Cannabis Patient's Guide to CBD Talking to your doctor Become a Legal Medical Marijuana Patient The Medical Cannabis Patient’s Guide for U.S. Travel Guide to Using Medical Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Arthritis and Medical Cannabis Cancer and Medical Cannabis Chronic Pain and Medical Cannabis Gastrointestinal Disorders and Medical Cannabis HIV/AIDS and Medical Cannabis Movement Disorders and Medical Cannabis Multiple Sclerosis and Medical Cannabis Aging and Medical Cannabis Veterans and Medical Cannabis Medical Marijuana Conditions in Your Area Growing Cannabis Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources Medical Cannabis Continuing Medical Education (CME) Cannabis Safety Medical Cannabis Research
- Legal Legal
Advocacy ASA Chapters Start an ASA Chapter Take Action Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
Policy Policy Positions Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Recognizing Science using the Data Quality Act Data Quality Act Briefs Fact Sheet on ASA's Data Quality Act Petition to HHS ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit Reports 2021 State of the States Cannabis and Cannabis Resin- Critical Review Preparation Document Medical Cannabis in America
- News News
- Join Join
Washington, DC -- Americans for Safe Access (ASA) applauds the passage of H.R. 3617, the Marijuana Opportunity Reinvestment and Expungement Act (MORE Act), in the House Judiciary Committee today.
In December 2020, the MORE Act was passed on the full floor of the House of Representatives by a vote of 228 to 164, but was not considered for a vote on the Senate floor in the 116th Congress.
Even though medical cannabis is legal in 37 states, it is illegal for cannabis and other Schedule I substances to be “prescribed, dispensed, or administered for medical use” at the federal level. To resolve this federal/state conflict, the bill would remove cannabis from Schedule I of the Controlled Substances Act, decriminalize cannabis, provide for reinvestment in certain people adversely impacted by the War on Drugs, and provide for the expungement of certain cannabis offenses.
ASA has been working to urge Congress to deschedule cannabis since the organization was founded in 2002. The Schedule 1 classification is given to substances thought to have no medical value and is incredibly archaic -- even the World Health Organization has deemed cannabis to have medical value.
“If this bill is signed into law, patients across the country, including veterans, can use this medicine without fear of losing any of their civil rights and protections.
“Moreover, this bill would remove barriers to cannabis research, and insurance companies may be encouraged to cover the costs of medical cannabis for patients.
“While ASA celebrates this move toward progress, we also look forward to continuing to advocate for medical cannabis patients’ rights and hope to see more emphasis on medical cannabis protections and exemptions in future cannabis policy discussions.
“If this legislation is signed into law, it will represent one of the greatest steps toward cannabis policy progress to date,” said Debbie Churgai, ASA executive director.
ABOUT AMERICANS FOR SAFE ACCESS
Americans for Safe Access (ASA), a national nonprofit (501(c)(3)), is the largest national member-based organization of patients, medical professionals, scientists, and concerned citizens promoting safe and legal access to cannabis for therapeutic use and research, with over 150,000 advocates in all 50 states.